{"id":826166,"date":"2022-10-10T19:26:39","date_gmt":"2022-10-10T17:26:39","guid":{"rendered":"https:\/\/15.161.165.86\/non-categorizzato\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/"},"modified":"2022-10-10T19:26:39","modified_gmt":"2022-10-10T17:26:39","slug":"sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/","title":{"rendered":"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer"},"content":{"rendered":"MENLO PARK, Calif.--(BUSINESS WIRE)--#ChiefBusinessOfficer--Sudo Biosciences (\u201cSudo\u201d), a biopharmaceutical company committed to designing and developing a broad pipeline of best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the appointment of Imran Babar, Ph.D., as chief business officer. Dr. Babar is an accomplished industry leader with broad experience in healthcare strategy, life sciences finance, operations and business development.\n\n\n\n\u201cImran brings to Sudo extensive experience in corporate strategy and business development, as well as his track record of financing and building biotech companies. He is exactly the type of leader Sudo needs as we advance into our next phase of growth,\u201d said Scott Byrd, C<div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>MENLO PARK, Calif.&#8211;(BUSINESS WIRE)&#8211;#ChiefBusinessOfficer&#8211;Sudo Biosciences (\u201cSudo\u201d), a biopharmaceutical company committed to designing and developing a broad pipeline of best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the appointment of Imran Babar, Ph.D., as chief business officer. Dr. Babar is an accomplished industry leader with broad experience in healthcare strategy, life sciences finance, operations and [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-826166","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer - BeBeez\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif.--(BUSINESS WIRE)--#ChiefBusinessOfficer--Sudo Biosciences (\u201cSudo\u201d), a biopharmaceutical company committed to designing and developing a broad pipeline of best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the appointment of Imran Babar, Ph.D., as chief business officer. Dr. Babar is an accomplished industry leader with broad experience in healthcare strategy, life sciences finance, operations and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-10T17:26:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer\",\"datePublished\":\"2022-10-10T17:26:39+00:00\",\"dateModified\":\"2022-10-10T17:26:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/\"},\"wordCount\":458,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/\",\"name\":\"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-10-10T17:26:39+00:00\",\"dateModified\":\"2022-10-10T17:26:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/","og_locale":"en_US","og_type":"article","og_title":"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer - BeBeez","og_description":"MENLO PARK, Calif.--(BUSINESS WIRE)--#ChiefBusinessOfficer--Sudo Biosciences (\u201cSudo\u201d), a biopharmaceutical company committed to designing and developing a broad pipeline of best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the appointment of Imran Babar, Ph.D., as chief business officer. Dr. Babar is an accomplished industry leader with broad experience in healthcare strategy, life sciences finance, operations and [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/","og_site_name":"BeBeez","article_published_time":"2022-10-10T17:26:39+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/"},"author":{"name":"","@id":""},"headline":"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer","datePublished":"2022-10-10T17:26:39+00:00","dateModified":"2022-10-10T17:26:39+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/"},"wordCount":458,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/","name":"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-10-10T17:26:39+00:00","dateModified":"2022-10-10T17:26:39+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/sudo-biosciences-appoints-imran-babar-ph-d-as-chief-business-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/826166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=826166"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/826166\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=826166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=826166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=826166"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=826166"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=826166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}